abstract |
<p> Compounds of formula (I '), methods for using the compounds in the inhibition of HPK1 activity and pharmaceutical compositions comprising said compounds are described. The compounds are useful in the treatment, prevention, or amelioration of diseases or disorders associated with HPK1 activity, such as cancer. </p> |